Figure 1.

Plot of mean HbA1c value (%) by visit (mITT population). Patients who received tofogliflozin in both the double‐blind and extension phases were referred to as the ‘tofo‐tofo group’, and patients who received placebo in the double‐blind phase and tofogliflozin in the extension phase were referred to as the ‘pla‐tofo group’. The graph includes data obtained from the first dose of tofogliflozin or placebo during the entire treatment period or up to the introduction of rescue medication, 1 day after the last dose of tofogliflozin or placebo, whichever is the earliest. Values are given as mean (%) ± standard error. Abbreviations: HbA1c, glycosylated haemoglobin; mITT, modified intention‐to‐treat; SE, standard error